Quantum BioPharma's 15min chart shows Bollinger Bands expanding downward, bearish Marubozu.

Quantum BioPharma's 15-minute chart has recently exhibited Bollinger Bands expanding downward, accompanied by a bearish Marubozu pattern on September 16, 2022, at 14:00. This trend suggests that the market is presently being driven by selling pressure, with sellers exerting control over market dynamics. Furthermore, the continuation of this bearish momentum is likely.

Quantum BioPharma's (NASDAQ: QNTM) stock chart has recently shown Bollinger Bands expanding downward, accompanied by a bearish Marubozu pattern on September 16, 2022, at 14:00. This technical indicator suggests that the market is currently driven by selling pressure, with sellers exerting control over market dynamics. The continuation of this bearish momentum is likely, indicating a period of market consolidation or potential downward movement.

On the heels of this bearish trend, Quantum BioPharma's licensee, Unbuzzd Wellness, will host an investor webinar on September 16, 2025, at 1:30 PM PT. The webinar will feature presentations from key executives, including CEO John Duffy, discussing Unbuzzd's scientifically-proven beverage that accelerates alcohol metabolism and reduces hangover symptoms. The webinar will focus on Unbuzzd's Regulation D 506(c) offering aiming to raise up to $5.0 million to support expansion plans and a possible IPO. Quantum BioPharma shareholders will not face dilution from this offering Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT^[1].

The webinar will delve into clinical study results, growth strategies, and plans for direct-to-consumer, distributor, and retail sales. A question-and-answer session will follow the presentation. CEO John Duffy commented, "We look forward to this opportunity to engage and inform current and potential investors about the rapidly expanding global market for unbuzzd. We will review the science behind how it works, and discuss results from our double-blind, placebo-controlled clinical study. We will also discuss the current opportunity to invest in our Regulation D 506(c) offering where we expect to raise up to US $5.0 million to support our aggressive expansion plans, and possible initial public offering."

Unbuzzd Wellness Inc. is a pioneering force in the wellness and recovery supplement landscape, backed by a world-class R&D team. The company's proprietary blend of vitamins, minerals, and herbs helps the body process alcohol faster, restore mental alertness, and improve cognition. Unbuzzd's scientifically-backed beverage has been shown to dramatically accelerate alcohol metabolism, speed the reduction of blood alcohol concentration (BAC), and reduce symptoms of intoxication and hangover Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT^[1].

Quantum BioPharma, a biopharmaceutical company dedicated to innovative assets and biotech solutions, retains ownership of 20.10% of Unbuzzd Wellness Inc. as of June 30, 2025, and receives royalty payments of 7% of sales until payments total $250 million. The company is also advancing Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation in preclinical models. This treatment approach has the potential to transform the lives of patients suffering from multiple sclerosis Quantum BioPharma Receives BUY Rating and $45 Price Target from Kingswood Capital Partners^[2].

Investors are urged to refer to additional information relating to Quantum BioPharma, including its annual information form, which can be located on the SEDAR+ website at www.sedarplus.ca and on the EDGAR section of the United States Securities and Exchange Commission’s website at www.sec.gov for a more complete discussion of such risk factors and their potential effects.